News about Global Pharma

Phosplatin with NIH start patient dosing in stage 2 preliminary of PT-112

Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company, announced the first patient has been treated in a phase 2 clinical trial of the company's lead therapeutic candidate, PT-112, in patients with recurrent thymic epithelial tumours (TETs), specifically thymoma and thymic carcinoma.

Global Pharma | 15/04/2022 | By Sudeep Soparkar |  292

Kyttaro and Lily come together to get license deal

UK-based startup Kyttaro and Eli Lilly have announced a new licensing deal.

Global Pharma | 14/04/2022 | By Sudeep Soparkar |  1130

US FDA approval: Lupin can now market its generic drugs

In its recent statement Lupin has said that it received approval from the US health regulator to market Efinaconazole topical solution, used to treat fungal toenail infections, in the American market

Global Pharma | 07/03/2022 | By Darshana |  390

UK-India innovation centre kick-starts to create a ?hot spot? for sustainable cooling innovation

The Centre of Excellence in Sustainable Cooling and Cold-Chain will conduct state-of-the-art applied research in food and vaccine distribution, supporting the roll-out of affordable, energy resilient, low emission cold-chain systems in India

Global Pharma | 04/03/2022 | By Darshana |  814

As US FDA lifts clinical hold, Covaxin to be evaluated as COVID-19 vaccine candidate in US

Covaxin (BBVI52), which has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is an investigational vaccine candidate product in the US

Global Pharma | 22/02/2022 | By Darshana |  269

With its Ascent Development Services merger, PharmaLex extends reach to Japan, East Asia and Southeast Asia

he Ascent merger offers access to an attractive client portfolio and adds substantially to PharmaLex?s global footprint, not only in the Japanese market but in other key markets throughout East and Southeast Asia. With deep roots in Asia, Ascent can act as a true partner in the region and, through the merger with PharmaLex

Global Pharma | 10/02/2022 | By Darshana |  897

DGFT removes restrictions on syringe exports

The government has removed restrictions on exports of syringes with immediate effect, according to a notification. Restrictions were imposed last year in the wake of the COVID-19 pandemic

Global Pharma | 04/02/2022 | By Darshana |  269

Aurobindo and Unichem recall products in US market

Aurobindo Pharma and Unichem Laboratories are recalling different products in the US market, the world's largest market for medicines, due to manufacturing issues. As per the latest enforcement report issued by the US Food and Drug Administration (FDA), Aurobindo's US-based unit is recalling 7,296 containers of hypertension drug Carvedilol tablets

Global Pharma | 08/12/2021 | By Darshana |  339

Syntegon enters strategic partnership with Bayer

Syntegon (formerly Bosch Packaging Technology), has entered a strategic partnershop with Bayer for the development of new continuous manufacturing processes for oral solid dosage (OSD) forms. The cooperation is based on the Xelum platform developed by the Syntegon subsidiary

Global Pharma | 18/11/2021 | By Darshana |  319

US FDA issues final order and guidance on surgical staplers and staples for internal use

The agency issued a final order reclassifying surgical staplers for internal use from Class I (general controls) to Class II (special controls) and requiring them to undergo premarket review. As a result, surgical staplers for internal use will be subject to more stringent regulatory requirements, including requiring premarket notification and special

Global Pharma | 11/10/2021 | By Darshana |  342